Funding Round

Jord BioScience Secures Series B Funding to Advance Microbial Solutions for Agriculture

Jord BioScience closed its Series B funding round to accelerate the developments of its microbial technology development.
Image provided by Jord BioScience.

Key Takeaways

  • Jord BioScience closed its Series B funding round to scale microbial technology development.
  • Lead investor Silver Blue LLC was joined by Discovery Capital Funding, SSBCI Direct Investment, and existing investors.
  • Funding will support the commercialization of next-generation microbial crop inputs.
  • Jord BioScience leverages a 6,500+ isolate microbial bank for innovative agricultural solutions.

Jord BioScience Announces Series B Funding Round

Jord BioScience, a company specializing in science-driven microbial solutions for agriculture, has successfully closed its Series B funding round. The investment will accelerate the development and commercialization of next-generation crop inputs aimed at enhancing microbial technology for improved agricultural productivity.

“This funding round marks a significant milestone for Jord BioScience, validating our partnership approach and the true potential of our microbial solutions to transform agriculture,” said Dr. Keri Carstens, President and CEO of Jord BioScience. “With this investment, we’re poised to scale our operations to help biologicals and crop inputs companies accelerate product discovery and innovation for farmers worldwide.”


Investment and Strategic Partners of Jord BioScience

The Series B round was led by Silver Blue LLC, a Maryland-based investment firm specializing in agrifoodtech. Additional contributions came from Discovery Capital Funding, the Small Business Credit Initiative (SSBCI) Direct Investment Program, and existing investors.

According to Francis Goelet, Director at Silver Blue LLC, “While biological innovation continues to evolve, Jord BioScience stands out by offering a fast and cost-effective approach to product differentiation, life cycle management, and revenue generation for agricultural companies. We believe Jord’s technology can bring improved consistency of performance to the biological industry at a time when farmers are under pressure to produce more food while navigating financial and environmental pressures.”


Advancing Microbial Crop Inputs

Jord BioScience was founded on over 30 years of microbial science research by Dr. Linda Kinkel, Chief Science Officer. The company collaborates with leading agribusinesses to accelerate the development of biological solutions for major crops, including:

  • Corn
  • Soybeans
  • Canola
  • Wheat
  • Specialty crops

At the core of Jord BioScience’s approach is its extensive microbial bank of 6,500+ isolates, collected from diverse global soils. These isolates work to enhance, protect, and promote plant health through distinct biological mechanisms.


Future Outlook

With the newly secured funding, the Minneapolis-based company aims to:

  • Expand microbial research and development for commercial agricultural use.
  • Scale operations to fast-track biological product discovery.
  • Support agribusiness partners in optimizing microbial solutions for farmers.
  • Increase efficiency and performance reliability of biological crop inputs.

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

Leave a Reply